Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 3
2023 4
2024 10
2025 12
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean tsuru t[au] (309 results)?
Combination therapy with cetirizine and anti-PD-1 antibody suppresses colitis-induced colon tumor formation in mice.
Maruyama Y, Hosonuma M, Toyoda H, Funayama E, Sasaki A, Baba Y, Tajima K, Nakashima R, Sasaki A, Shida M, Tsurui T, Tsuji M, Tsunoda T, Shimane T, Kiuchi Y, Yoshimura K, Kuramasu A. Maruyama Y, et al. Among authors: tsurui t. Eur J Pharmacol. 2025 Jul 15;999:177704. doi: 10.1016/j.ejphar.2025.177704. Epub 2025 May 2. Eur J Pharmacol. 2025. PMID: 40320111
Combination therapy with levofloxacin and the probiotic Clostridium butyricum MIYAIRI 588 enhances immune checkpoint inhibitor efficacy.
Tajima K, Hosonuma M, Funayama E, Isobe J, Baba Y, Murayama M, Narikawa Y, Toyoda H, Tsurui T, Maruyama Y, Sasaki A, Amari Y, Yamazaki Y, Nakashima R, Shida M, Sasaki A, Sambe T, Wada S, Tsuji M, Kiuchi Y, Kobayashi S, Kuramasu A, Tsunoda T, Mori M, Koyanagi K, Yoshimura K. Tajima K, et al. Among authors: tsurui t. Int J Cancer. 2025 Sep 1;157(5):993-1005. doi: 10.1002/ijc.35472. Epub 2025 Jun 6. Int J Cancer. 2025. PMID: 40478177
Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody.
Murayama M, Hosonuma M, Kuramasu A, Kobayashi S, Sasaki A, Baba Y, Narikawa Y, Toyoda H, Isobe J, Funayama E, Tajima K, Sasaki A, Maruyama Y, Yamazaki Y, Shida M, Hamada K, Hirasawa Y, Tsurui T, Ariizumi H, Ishiguro T, Suzuki R, Ohkuma R, Kubota Y, Horiike A, Sambe T, Tsuji M, Wada S, Kobayashi S, Shimane T, Tsunoda T, Kobayashi H, Kiuchi Y, Yoshimura K. Murayama M, et al. Among authors: tsurui t. Sci Rep. 2024 May 17;14(1):11325. doi: 10.1038/s41598-024-59677-1. Sci Rep. 2024. PMID: 38760458 Free PMC article.
MHC class I polypeptide-related sequence B shedding modulates pancreatic tumor immunity via the activation of NKG2DLow T cells.
Toyoda H, Kuramasu A, Hosonuma M, Murayama M, Narikawa Y, Isobe J, Baba Y, Tajima K, Funayama E, Shida M, Maruyama Y, Sasaki A, Hirasawa Y, Tsurui T, Ariizumi H, Ishiguro T, Suzuki R, Kobayashi S, Horiike A, Hida N, Sambe T, Nobe K, Wada S, Kobayashi H, Tsuji M, Kobayashi S, Tsunoda T, Kudo Y, Kiuchi Y, Yoshimura K. Toyoda H, et al. Among authors: tsurui t. Sci Rep. 2024 Oct 8;14(1):23401. doi: 10.1038/s41598-024-73712-1. Sci Rep. 2024. PMID: 39379424 Free PMC article.
Inosine shapes PD-1 blockade responses and synergizes with dual PD-1/CTLA-4 immunotherapy to enhance antitumor immunity.
Narikawa Y, Kuramasu A, Hosonuma M, Murayama M, Funayama E, Sasaki A, Baba Y, Toyoda H, Isobe J, Tajima K, Nakashima R, Sasaki A, Maruyama Y, Yamazaki Y, Shida M, Tsurui T, Hirasawa Y, Ariizumi H, Ishiguro T, Suzuki R, Ohkuma R, Kubota Y, Sambe T, Tsuji M, Wada S, Horiike A, Kobayashi S, Tsunoda T, Kobayashi S, Kobayashi H, Oguchi T, Shimane T, Kiuchi Y, Yoshimura K. Narikawa Y, et al. Among authors: tsurui t. Cancer Immunol Immunother. 2025 Aug 19;74(9):289. doi: 10.1007/s00262-025-04111-2. Cancer Immunol Immunother. 2025. PMID: 40828195 Free PMC article.
Ki-67 expression in anti-programmed cell death protein-1 antibody-bound CD8+ T cells as a predictor of clinical benefit.
Tsurui T, Hosonuma M, Sasaki A, Maruyama Y, Amari Y, Funayama E, Tajima K, Toyoda H, Isobe J, Yamazaki Y, Baba Y, Shida M, Udaka Y, Mura E, Suzuki R, Iriguchi N, Ishiguro T, Hirasawa Y, Ohkuma R, Shimokawa M, Ariizumi H, Kubota Y, Horiike A, Wada S, Kuramasu A, Tsuji M, Kiuchi Y, Tsunoda T, Yoshimura K. Tsurui T, et al. Discov Oncol. 2025 Mar 18;16(1):348. doi: 10.1007/s12672-025-02060-x. Discov Oncol. 2025. PMID: 40100476 Free PMC article.
Association between the ABCC11 gene polymorphism-determined earwax properties and external auditory canal microbiota in healthy adults.
Amari Y, Hosonuma M, Mizukami T, Isobe J, Azetsu Y, Funayama E, Maruyama Y, Tsurui T, Tajima K, Sasaki A, Yamazaki Y, Nakano R, Sano Y, Ishida A, Nakanishi T, Mochizuki S, Yoshizawa Y, Kumagai S, Yasuhara S, Ryu K, Oguchi T, Kuramasu A, Yoshimura K, Sambe T, Kobayashi S, Uchida N. Amari Y, et al. Among authors: tsurui t. Microbiol Spectr. 2025 Feb 4;13(2):e0169824. doi: 10.1128/spectrum.01698-24. Epub 2025 Jan 16. Microbiol Spectr. 2025. PMID: 39817749 Free PMC article.
Evaluation of patient immunocompetence for immune checkpoint inhibitor therapy using the psoas muscle index: a retrospective cohort study.
Tsurui T, Hamada K, Mura E, Suzuki R, Iriguchi N, Ishiguro T, Hirasawa Y, Ohkuma R, Shimokawa M, Ariizumi H, Kubota Y, Horiike A, Wada S, Yoshimura K, Tsuji M, Kiuchi Y, Tsunoda T. Tsurui T, et al. Front Oncol. 2025 Feb 6;15:1499650. doi: 10.3389/fonc.2025.1499650. eCollection 2025. Front Oncol. 2025. PMID: 39980541 Free PMC article.
Veillonella and Streptococcus are associated with aging of the gut microbiota and affect the efficacy of immune checkpoint inhibitors.
Hirasawa Y, Isobe J, Hosonuma M, Tsurui T, Baba Y, Funayama E, Tajima K, Murayama M, Narikawa Y, Toyoda H, Shida M, Sasaki A, Maruyama Y, Amari Y, Mura E, Suzuki R, Iriguchi N, Ishiguro T, Ohkuma R, Shimokawa M, Ariizumi H, Kubota Y, Horiike A, Sambe T, Uchida N, Wada S, Kobayashi S, Kiuchi Y, Kuramasu A, Yoshimura K, Tsunoda T. Hirasawa Y, et al. Among authors: tsurui t. Front Immunol. 2025 May 22;16:1528521. doi: 10.3389/fimmu.2025.1528521. eCollection 2025. Front Immunol. 2025. PMID: 40475781 Free PMC article.
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice.
Funayama E, Hosonuma M, Tajima K, Isobe J, Baba Y, Murayama M, Narikawa Y, Toyoda H, Tsurui T, Maruyama Y, Sasaki A, Amari Y, Yamazaki Y, Nakashima R, Uchiyama J, Nakano R, Shida M, Sasaki A, Udaka Y, Oguchi T, Sambe T, Kobayashi S, Tsuji M, Kiuchi Y, Kim YG, Wada S, Tsunoda T, Akiyama M, Nobe K, Kuramasu A, Yoshimura K. Funayama E, et al. Among authors: tsurui t. Biomed Pharmacother. 2025 Jan;182:117749. doi: 10.1016/j.biopha.2024.117749. Epub 2024 Dec 23. Biomed Pharmacother. 2025. PMID: 39719740 Free article.
30 results